Citation Impact
Citing Papers
A Small-Molecule Modulator of Poly-α2,8-Sialic Acid Expression on Cultured Neurons and Tumor Cells
2001 StandoutScienceNobel
Infectious enveloped RNA virus antigenic chimeras.
1992 StandoutNobel
Single-crystal x-ray diffraction structures of covalent organic frameworks
2018 StandoutScienceNobel
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
2001
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Angiogenesis inhibition: A review
1994
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
How Tumors Become Angiogenic
1996
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Ribosome-inactivating proteins from plants
1993
Dynamic imine chemistry
2012 StandoutNobel
Vascular targeting—a new approach to the therapy of solid tumors
1994
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Antibody targeted drugs as cancer therapeutics
2006
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer
2002
Oncogenes as inducers of tumor angiogenesis
1995
Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
1996 StandoutNature
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
Microvascular Modifications in Diabetic Retinopathy
2011
The microenvironment of the tumour–host interface
2001 StandoutNature
A brief survey of methods for preparing protein conjugates with dyes, haptens and crosslinking reagents
1992
Mechanisms and effectors of MIF-dependent promotion of tumourigenesis
2003
Vascular‐targeting therapies for treatment of malignant disease
2004
Synapse-Specific, Long-Term Facilitation of Aplysia Sensory to Motor Synapses: A Function for Local Protein Synthesis in Memory Storage
1997 StandoutNobel
The Role of Sequestration in G Protein-coupled Receptor Resensitization
1997 StandoutNobel
Ligand-targeted therapeutics in anticancer therapy
2002
Cancer-related inflammation
2008 StandoutNature
Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [γ-32P]-ATP
1996 StandoutNobel
Protein Sequence Editing of SKN-1A/Nrf1 by Peptide:N-Glycanase Controls Proteasome Gene Expression
2019 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Arming antibodies: prospects and challenges for immunoconjugates
2005
Selective translocation of the A chain of diphtheria toxin across the membrane of purified endosomes.
1992
Dynamic donor–acceptor [2]catenanes
2007 StandoutNobel
Recombinant Toxins for Cancer Treatment
1991 Science
Chemical Topology: Complex Molecular Knots, Links, and Entanglements
2011 StandoutNobel
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
2001
Immunotoxins: A New Approach to Cancer Therapy
1983 Science
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
1999 StandoutNobel
A Metal-Chelating Lipid for 2D Protein Crystallization via Coordination of Surface Histidines
1997 StandoutNobel
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Vascular Targeting Agents as Cancer Therapeutics
2004
Chemical Glycobiology
2001 StandoutScienceNobel
Positive Cooperativity in the Template-Directed Synthesis of Monodisperse Macromolecules
2012 StandoutNobel
Dynamic Transformation between Covalent Organic Frameworks and Discrete Organic Cages
2020 StandoutNobel
Ketone Isosteres of 2-N-Acetamidosugars as Substrates for Metabolic Cell Surface Engineering
2001 StandoutNobel
Dynamic Combinatorial Chemistry
2006 Standout
Purification and enzymatic properties of peptide:N-glycanase from C3H mouse-derived L-929 fibroblast cells. Possible widespread occurrence of post-translational remodification of proteins by N-deglycosylation
1994
Cell Surface Engineering by a Modified Staudinger Reaction
2000 StandoutScienceNobel
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
2002
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Tat-mediated delivery of heterologous proteins into cells.
1994
Angiogenesis: Models and Modulators
1995
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
1999 StandoutScience
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A.
1980
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
1989 StandoutScience
Investigating Cellular Metabolism of Synthetic Azidosugars with the Staudinger Ligation
2002 StandoutNobel
Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature
1997 Science
Growth Factors and Cancer
1991 StandoutScience
Metabolic incorporation of unnatural sialic acids into Haemophilus ducreyi lipooligosaccharides
2003 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Imaging the glycome
2008 StandoutNobel
Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
1984
Imaging Cell Surface Glycans with Bioorthogonal Chemical Reporters
2007 StandoutNobel
Immunotoxins
1986
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Ricin: structure, mode of action, and some current applications
1994
Synergy between an antiangiogenic integrin αvantagonist and an antibody–cytokine fusion protein eradicates spontaneous tumor metastases
1999
Redesigning Nature's Poisons to Create Anti-Tumor Reagents
1987 Science
Surface molecular recognition
2001 StandoutNobel
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Chemical Glycoproteomics
2016 StandoutNobel
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
1999 StandoutScience
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of P E Thorpe being referenced
Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin
1988
Conjugation of monoclonal antibodies to a synthetic peptide substrate for protein kinase: a method for labelling antibodies with 32P
1988
Retargeting adenoviral vectors to improve gene transfer into tumors
2010
VEGF–VEGF receptor complexes as markers of tumor vascular endothelium
2001
Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.
1993
Neuronotoxic effects of monoclonal anti-Thy 1 antibody (OX7) coupled to the ribosome inactivating protein, saporin, as studied by suicide transport experiments in the rat
1989
Targeting the vasculature of solid tumors
1994
Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages.
1988
Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.
1988
Comparison of Two Anti-Thy 1.1-Abrin A-Chain Immunotoxins Prepared With Different Cross-Linking Agents: Antitumor Effects, In Vivo Fate, and Tumor Cell Mutants
1987
Heparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice.
1993
Vascular endothelial growth factor and vascular targeting of solid tumors.
2002
Selective killing of contaminating human fibroblasts in epithelial cultures derived from colorectal tumours using an anti Thy-1 antibody-ricin conjugate
1985
[16] Preparation of antibody—toxin conjugates
1985
Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature.
1998
Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugate
1982 Nature
Toxicity of diphtheria toxin for lymphoblastoid cells is increased by conjugation to antilymphocytic globulin
1978 Nature
Immunotoxins containing ricin or its A chain.
1991
Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin.
1987
Abrogation of the non-specific toxicity of abrin conjugated to anti-lymphocyte globulin.
1981
The removal of carbohydrates from ricin with endoglycosidases H, F and D and α-mannosidase
1985
Purification of ricin A1, A2, and B chains and characterization of their toxicity.
1986
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
2000
Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.
1988
Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
1990